Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- BLU.TO
- Price
- -
- Stock movement down
- -0.02 (-0.10%)
- Company name
- BELLUS Health Inc.
- Exchange
- (TO ,
- Currency
- CAD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 2.47B
- Ent value
- 2.40B
- Price/Sales
- 164686.52
- Price/Book
- 6.70
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- 71.16%
- 1 year return
- 60.46%
- 3 year return
- 12.39%
- 5 year return
- 57.88%
- 10 year return
- 35.96%
Last updated: 2024-12-17
DIVIDENDS
BLU.TO does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 164686.52 |
| Price to Book | 6.70 |
| EV to Sales | 159704.12 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 126.81M |
| EPS (TTM) | -0.69 |
| FCF per share (TTM) | -0.70 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 15.00K |
| Gross profit (TTM) | 15.00K |
| Operating income (TTM) | -90.31M |
| Net income (TTM) | -86.79M |
| EPS (TTM) | -0.69 |
| EPS (1y forward) | -1.25 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 100.00% |
| Operating margin (TTM) | -214748.36% |
| Profit margin (TTM) | -214748.36% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 85.38M |
| Net receivables | 2.04M |
| Total current assets | 327.71M |
| Goodwill | 0.00 |
| Intangible assets | 50.10M |
| Property, plant and equipment | 0.00 |
| Total assets | 379.54M |
| Accounts payable | 9.44M |
| Short/Current long term debt | 1.20M |
| Total current liabilities | 9.80M |
| Total liabilities | 10.64M |
| Shareholder's equity | 368.90M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -89.22M |
| Capital expenditures (TTM) | 0.00 |
| Free cash flow (TTM) | -89.22M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -23.53% |
| Return on Assets | -22.87% |
| Return on Invested Capital | -23.50% |
| Cash Return on Invested Capital | -24.16% |
STOCK INFORMATION
Downside potential
Loading...
Downside potential data
| BLU.TO | S&P500 | |
| Current price drop from All-time high | -99.51% | -8.29% |
| Highest price drop | -99.98% | -56.47% |
| Date of highest drop | 5 Dec 2016 | 9 Mar 2009 |
| Avg drop from high | -80.55% | -11.07% |
| Avg time to new high | 104 days | 12 days |
| Max time to new high | 4823 days | 1805 days |
COMPANY DETAILS
Marketcap
2.47B
Marketcap category
Mid-cap
Description
BELLUS Health Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. BELLUS Health Inc. was incorporated in 1993 and is based in Laval, Canada. As of June 28, 2023, BELLUS Health Inc. operates as a subsidiary of GSK plc.
Employees
74
Website
Investor relations
-
SEC filings
CEO
Country
Canada
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found